Revenue $3.87B, up 23.0% on a year earlier. Pharmacy Solutions Revenue $3.41B, up 22.1%. Diluted EPS $0.38 against $0.13.
| Q2 FY26 | Q1 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $3.87B | $3.61B | $3.15B | +23.0% |
| Operating income | $130.39M | $121.45M | $48.56M | +168.5% |
| Net income | $84.21M | $148.61M | $28.21M | +198.5% |
| Diluted EPS | $0.38 | $0.67 | $0.13 | |
| Operating cash flow | $43.92M | $122.94M | $49.08M | -10.5% |
| Capital expenditures | -$29.03M | -$21.54M | -$24.43M | |
| Free cash flow | $14.88M | $101.40M | $24.65M | -39.6% |
| Q2 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|
| Net revenue growth | 23% | 15.29% | |
| Pharmacy Solutions Revenue | $3.41B | $2.79B | +22.1% |
| Provider Services Revenue | $466.00M | $358.00M | +30.2% |
| Pharmacy Solutions Revenue Growth | 22% | 31.98% | |
| Provider Services Revenue Growth | 30% | -41.88% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “BrightSpring Health Services (BTSG) Q2 FY26 earnings: results and KPIs”, stockatlas.com/companies/BTSG/earnings/2026-q2/, data as of 3 November 2026. Links to this page are welcome.
